ESR1 and breast cancer: TNBCs lack the expression of estrogen receptors (ER), progesterone receptors, and human epidermal growth factor receptor-2, and have highly aggressive characteristics; therefore, patients with TNBCs have poorer prognoses than those with other types of breast cancer.